Israeli stocks are broadly lower day after vote

March 29, 2006 15:27


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Israeli stocks were broadly lower Wednesday amid uncertainty about the future government following Kadima's narrow election win. The TA-25 and TA-100 indexes were each down 1.8 percent, paced by declines in the financial sector, which is most sensitive to economic developments. The Finance-15 index lost 2.9%. Kadima landed 28 seats in Tuesday's election but traders had hoped for a stronger showing to ensure continuation of the party's economic policies. Now, however, the future is uncertain because Kadima must put together a coalition that could result in a move away from the status quo. Shares of Bank Leumi and Bank Hapoalim were among the decliners despite posting higher fourth-quarter earnings. Israel Discount Bank fell after swinging to a fourth-quarter loss after a payment related to a money-laundering probe at its New York operations and an early retirement provision.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection